Testosterone decline is a near-universal feature of male ageing, yet the decision to pursue pharmaceutical intervention is not one every man is ready or suited to make. Natural testosterone supplements derived from plants and herbs have been used for decades and recently seen as one of the best alternative remedies for men. However, the remain question is:
Which herb is considered amongst the best for testosterone?
This article examines the ten most clinically investigated natural herbs with testosterone-supporting properties, evaluating each through the lens of randomised controlled trials, non-randomised clinical studies, in-vitro receptor assays, and in-vivo animal models. The herbs reviewed are ashwagandha, Tongkat Ali, fenugreek, Shilajit, maca root, Tribulus terrestris, stinging nettle root, Panax ginseng, boron, and Mucuna pruriens.
Each herb is assessed not only for its estimated efficacy but for the likelihood that a given man — depending on his age and hormonal baseline — will derive meaningful benefit from supplementation.
| Herb | Primary Mechanism | Best Age Group | Overall Evidence Quality | Typical Efficacy Range |
| Ashwagandha | Cortisol reduction / HPG axis disinhibition | 36–55 | Strong (multiple RCTs) | 14–40% total T increase |
| Tongkat Ali | LH stimulation / Leydig cell steroidogenesis / aromatase inhibition | 36–55 and 56+ | Strong (9 RCTs + meta-analysis) | 15%–100%+ total T increase |
| Fenugreek | Aromatase inhibition / 5-AR inhibition / free T preservation | 36–55 | Moderate–Strong | 40–46% free T increase |
| Shilajit | Mitochondrial energy / gonadotropin stimulation | 56+ | Moderate (1 strong RCT) | ~20% total and free T increase |
| Maca Root | Central HPG modulation / libido pathways | 36–55 | Weak for T; strong for libido | Minimal direct T effect |
| Tribulus | Gonadotropin stimulation (hypogonadal men only) | 36–55 | Weak in healthy men | No consistent T effect in eugonadal men |
| Stinging Nettle | SHBG displacement / free T liberation | 56+ | Moderate (in-vitro strong; clinical limited) | Modest free T increase; no total T change |
| Panax Ginseng | Leydig cell stimulation / nitric oxide / antioxidant | 56+ | Moderate (strong for ED outcomes) | Modest free T; strong erectile function data |
| Boron | SHBG suppression / oestradiol reduction | 56+ | Moderate–Strong | 28% free T increase; −39% oestradiol |
| Mucuna Pruriens | Prolactin suppression / LH stimulation | 20–55 | Moderate (subfertile populations) | ~38% T increase in hyperprolactinaemic men |
1. Ashwagandha (Withania somnifera)
Mechanism:
Ashwagandha is an adaptogenic root that primarily works by reducing cortisol, the body’s dominant stress hormone. Since cortisol and testosterone exist in an inverse hormonal relationship — high cortisol suppresses the hypothalamic-pituitary-gonadal (HPG) axis — lowering cortisol creates an environment more permissive to testosterone production. Secondary mechanisms include antioxidant activity in Leydig cells and upregulation of luteinising hormone (LH) signalling.
Clinical evidence:
A well-designed double-blind RCT by Lopresti et al. (2019) found that 600 mg/day of ashwagandha root extract over 8 weeks produced a statistically significant 14.7% increase in serum testosterone compared to placebo in healthy men aged 40–70. An earlier RCT by Wankhede et al. (2015) in resistance-trained men aged 18–50 reported testosterone increases of approximately 15%, alongside significant gains in muscle strength and recovery. A 2022 study specifically in men with stress-related subfertility documented testosterone increases of approximately 40% after 90 days, attributed largely to cortisol suppression. In-vitro studies confirm withanolides modulate androgen receptor expression, and in-vivo rodent models consistently demonstrate elevated serum testosterone and LH following standardised ashwagandha supplementation.
| Age Group | Efficacy Score | Likelihood of Benefit | Notes |
| 20–35 | 8/10 | High (70–80%) | Especially potent in stressed, overtrained, or sleep-deprived young men |
| 36–55 | 8.5/10 | High (75–85%) | Strongest RCT evidence base sits in this age band |
| 56+ | 7.5/10 | Moderate–High (60–70%) | Benefits likely but attenuated by age-related Leydig cell decline |
2. Tongkat Ali / Longjack (Eurycoma longifolia)
Mechanism:
Tongkat Ali contains over 65 identified bioactive compounds, with the most clinically studied being quassinoids (principally eurycomanone), glycosaponins, alkaloids, and eurypeptides. Its androgenic effects operate through several complementary pathways. At the hypothalamic-pituitary axis, eurycomanone stimulates greater pulsatile LH release from the pituitary, driving increased testosterone biosynthesis in Leydig cells. Eurypeptides enhance the enzymatic activity of CYP450c17 and e17, increasing upstream production of DHEA and testosterone, while quassinoids also inhibit aromatase, reducing conversion of testosterone to oestradiol and oestrone. Evidence regarding SHBG reduction is present but inconsistent across studies.
RCT evidence:
Tambi, Imran & Henkel (2012) — Late-Onset Hypogonadism. This frequently cited study enrolled 76 men with confirmed late-onset hypogonadism (LOH) from a broader pool of 320 patients. After one month of 200 mg/day of standardised water-soluble Tongkat Ali, a clinically meaningful normalisation of total testosterone was demonstrated. Although single-arm and open-label — limiting causal inference — its significance lies in confirming testosterone normalisation from a subnormal baseline in a real-world hypogonadal cohort.
Talbott, Talbott, George & Pugh (2013) — Moderately Stressed Adults. This double-blind, placebo-controlled trial enrolled 63 subjects (32 men, 31 women) screened for moderate stress and given 200 mg/day of standardised TA extract or placebo for 4 weeks. The TA group showed a significant improvement in cortisol (−16%) and testosterone status (+37%), alongside reductions in psychological tension (−11%), anger (−12%), and confusion (−15%). This study positions TA’s testosterone benefit as partially downstream of its adaptogenic cortisol-suppressing action, mechanistically aligned with ashwagandha.
Ismail, Wan Mohammad, George et al. (2012) — Healthy Married Men. A double-blind, placebo-controlled RCT using 300 mg of Physta® freeze-dried extract in 109 men aged 30–55 for 12 weeks. The TA group experienced improvements in libido (14% increase by week 12), sperm motility (44.4%), and semen volume (18.2%), with fat mass reduction in men with BMI ≥25. Importantly, no significant difference in total testosterone was found versus placebo in this healthy, eugonadal cohort — an important null result establishing the population-specificity of TA’s testosterone effects.
Chinnappan, George, Pandey, Narke & Choudhary (2021) — Ageing Hypogonadal Men. One of the most rigorous TA trials to date: a multi-centre, double-blind, placebo-controlled RCT enrolling 105 men aged 50–70 with testosterone below 300 ng/dL, randomised to 100 mg Physta®, 200 mg Physta®, or placebo for 12 weeks. Significant improvements in total testosterone were observed in both active arms versus placebo, providing the most direct RCT evidence for TA’s benefit in older hypogonadal men.
Chan, Stewart, Chester, Hamzah & Yusof (2021) — Healthy Young Men. A placebo-controlled RCT supplementing sedentary young males with 600 mg of TA for 8 weeks found no significant improvement in testosterone compared to placebo, though a significant intra-group improvement in SHBG was noted. This null result in healthy young eugonadal men is an important counterweight against generalised testosterone-boosting claims.
6-Month Concurrent Training RCT — Men with ADAM (2020). The longest TA RCT published to date. Forty-five men (mean age 47.4 years) with androgen deficiency of aging males (ADAM) were randomised into four groups: control + placebo; control + TA; concurrent training + placebo; concurrent training + TA. All groups received 200 mg TA or placebo for six months, with training groups exercising three times per week at progressive intensity. Erectile function improved in both active intervention groups, but total testosterone and erectile function improvements were greatest in the combined concurrent training + TA arm — demonstrating a meaningful synergistic interaction between supplementation and exercise that has not been observed to the same degree for most other herbs.
Non-RCT clinical evidence:
Henkel, Wang, Bassett et al. (2014) — Pilot Study in Physically Active Seniors. Thirteen male and 12 female physically active seniors aged 57–72 were supplemented with 400 mg TA extract daily for 5 weeks in a non-placebo-controlled pilot study. Both total and free testosterone concentrations increased significantly, alongside significant improvements in muscular force. The free testosterone increase in women was attributed to a decline in SHBG. While this carries a lower level of evidence than the RCTs, its relevance lies in extending TA’s evidence profile to the oldest cohort studied to date.
Tambi & Imran (2010) — Idiopathic Male Infertility. A non-randomised observational study in men with idiopathic infertility receiving TA supplementation over 9 months reported significant improvements in sperm concentration, motility, and serum testosterone, suggesting TA’s androgenic action extends through gonadotropin stimulation beyond the hypogonadism context alone.
Meta-analytic summary: A 2022 systematic review and meta-analysis (Leisegang et al.) following PRISMA guidelines identified nine studies in total, of which five RCTs were included in the quantitative synthesis. The random-effects model found a statistically significant increase in total testosterone (SMD = 1.352, 95% CI 0.565 to 2.138, p = 0.001), confirmed in the hypogonadism subgroup. Across the broader RCT body of evidence, nine trials have collectively reported increases in total or free testosterone ranging from 5% to over 100%, with the most substantial and consistent increases in older men with low-normal or subnormal baseline testosterone. A critical nuance from the meta-analysis: seven of the nine studies reported a significant improvement in total testosterone, but two reported null results — one when treatment was stopped after 3 weeks and one in healthy eugonadal young men at 8 weeks — confirming that response is both duration-dependent and population-dependent.
Standardisation note: Tongkat Ali extract containing less than 0.5% eurycomanone or less than 20% eurypeptides significantly reduces efficacy. This explains much of the inconsistency between commercial products and the variation seen across lower-quality studies. Clinically validated preparations (Physta®, LJ100) should be the reference standard when selecting a product.
Age group assessment:
| Age Group | Efficacy Score | Likelihood of Benefit | Key Evidence |
| 20–35 (healthy, eugonadal) | 4.5/10 | Low–Moderate (30–45%) | Chan 2021 RCT: null result; Ismail 2012 RCT: null for testosterone in healthy men |
| 20–35 (stressed / overtrained / suppressed T) | 7/10 | Moderate–High (60–70%) | Talbott 2013 RCT; Hamzah & Yusof 2003; in-vivo mechanistic data |
| 36–55 | 8/10 | High (70–80%) | Tambi 2012; Talbott 2013; 6-month ADAM RCT; meta-analysis confirmation |
| 56+ | 8.5/10 | High (72–82%) | Chinnappan 2021 (50–70 yr hypogonadal men); Henkel 2014 pilot (57–72 yr seniors) |
Recommended dose: 200–400 mg/day of standardised water-soluble extract (Physta® or LJ100, standardised to ≥0.8–1% eurycomanone and ≥22% eurypeptides). Minimum 4–6 weeks for measurable hormone changes; sustained benefit up to 6 months documented.
3. Fenugreek (Trigonella foenum-graecum)
Mechanism:
Fenugreek contains steroidal saponins called fenuside and protodioscin, which are thought to inhibit aromatase (the enzyme converting testosterone to oestradiol) and 5-alpha-reductase, thereby preserving free testosterone levels. Some studies also suggest direct stimulation of androgen receptor expression in target tissues.
Clinical evidence:
A randomised, double-blind, placebo-controlled trial by Maheshwari et al. (2017) found that 500 mg of fenugreek extract daily over 12 weeks increased total testosterone by 46% and free testosterone by 41% in male participants aged 35–65. A separate trial by Steels et al. (2011) in healthy men aged 25–52 using Testofen (a standardised fenugreek extract at 600 mg/day) reported significantly improved self-reported libido and sexual performance, with modest but significant increases in total testosterone. In-vitro binding assays confirm meaningful anti-aromatase activity of fenugreek saponins, and in-vivo rodent studies show dose-dependent increases in serum testosterone and LH with oral fenugreek administration.
Age group assessment:
| Age Group | Efficacy Score | Likelihood of Benefit | Notes |
| 20–35 | 6.5/10 | Moderate (50–60%) | Useful particularly in men with high oestrogen conversion; libido benefits well-documented |
| 36–55 | 7/10 | Moderate–High (60–70%) | Most studied in this cohort; anti-aromatase effect becomes increasingly relevant |
| 56+ | 6/10 | Moderate (45–55%) | Aromatase activity rises with age and adiposity, improving mechanistic fit |
Recommended dose: 500–600 mg/day of standardised extract (Testofen or equivalent, standardised to 50% fenuside).
4. Shilajit (Asphaltum punjabianum)
Mechanism:
Shilajit is a mineral-rich resinous exudate from Himalayan rock formations, dense in fulvic acid and dibenzo-α-pyrones. It enhances mitochondrial electron transport chain efficiency and ATP production — the cellular energy currency underpinning testosterone biosynthesis in Leydig cells. Secondary mechanisms include increases in gonadotropins (FSH and LH) in both animal and human models, and antioxidant protection of gonadal tissue from oxidative damage.
Clinical evidence:
A double-blind, placebo-controlled RCT by Pandit et al. (2016) in healthy male volunteers aged 45–55 found that 250 mg of purified Shilajit twice daily for 90 days produced a statistically significant 20.45% increase in total testosterone, a 19.17% increase in free testosterone, and a 19% increase in DHEA, with no adverse effects reported. In-vivo rat studies confirm pronounced increases in testosterone and sperm motility following Shilajit extract administration. The mitochondrial mechanism makes Shilajit particularly relevant to older men, whose cellular energy metabolism is declining independently of hormonal factors.
Age group assessment:
| Age Group | Efficacy Score | Likelihood of Benefit | Notes |
| 20–35 | 6/10 | Moderate (45–55%) | Less compelling unless there is mitochondrial dysfunction or fatigue |
| 36–55 | 7.5/10 | Moderate–High (65–72%) | RCT evidence base sits directly in this cohort |
| 56+ | 8/10 | High (70–78%) | Strongest mechanistic and clinical case for older men; mitochondrial decline is age-dependent |
Recommended dose: 250–500 mg/day of purified Shilajit resin standardised to ≥50% fulvic acid.
5. Maca Root (Lepidium meyenii)
Mechanism:
Maca does not appear to directly raise serum testosterone in most studies. Instead, it acts primarily on the central nervous system, improving libido, energy, and mood through glucosinolates and macamides. Some studies indicate modulation of the HPG axis at the hypothalamic level, and in-vitro evidence shows partial androgenic receptor activity. Its testosterone-elevating effects in humans are modest and inconsistent across trials.
Clinical evidence:
A systematic review by Shin et al. (2010) found that maca significantly improved sexual dysfunction and libido in men across age groups, but effects on testosterone were minimal. A double-blind RCT by Gonzales et al. (2003) in men aged 21–56 found improved self-reported sexual desire with 1,500–3,000 mg of maca for 12 weeks, with no significant change in testosterone, LH, FSH, or oestradiol. In-vivo studies in male rodents show enhanced sexual behaviour and sperm production, possibly via central dopaminergic and androgenic pathways. Maca’s evidence base is therefore strongest for sexual function and quality of life rather than testosterone elevation per se.
Age group assessment:
| Age Group | Efficacy Score | Likelihood of Benefit | Notes |
| 20–35 | 5/10 | Moderate (40–50%) | Better for libido and energy than measurable testosterone elevation |
| 36–55 | 5.5/10 | Moderate (45–55%) | Useful adjunct; do not expect serum T shifts |
| 56+ | 5/10 | Low–Moderate (35–45%) | Modest but real quality-of-life and sexual function benefits |
Recommended dose: 1,500–3,000 mg/day of gelatinised maca powder or 500–1,000 mg of maca extract.
6. Tribulus Terrestris
Mechanism:
Tribulus was historically touted as a testosterone booster based on its steroidal saponin protodioscin, theorised to convert to DHEA and subsequently testosterone via the androgen biosynthesis pathway. This mechanism has not been confirmed in healthy human males. Some evidence does support gonadotropin stimulation in infertile or hypogonadal men specifically, and animal models consistently show androgenic effects.
Clinical evidence:
Multiple RCTs in healthy eugonadal men have found no significant effect on testosterone levels from Tribulus supplementation. A 2016 systematic review by Qureshi et al. concluded that while Tribulus improved erectile function scores and sperm parameters in infertile men, it did not raise serum testosterone in men with normal hormonal baselines. A clinical study by Roaiah et al. (2016) in infertile men did report significant improvements in both testosterone and sperm quality, and in-vivo rabbit and rat studies show consistent dose-dependent androgenic effects — making the animal mechanistic case considerably stronger than the human evidence.
Age group assessment:
Age Group | Efficacy Score | Likelihood of Benefit | Notes |
| 20–35 | 4.5/10 | Low (25–35%) | Limited and largely null evidence in healthy young men |
| 36–55 | 4.5/10 | Low–Moderate (30–40%) | Modest potential benefit in men with suboptimal reproductive function |
| 56+ | 3.5/10 | Low (20–30%) | Not well-evidenced for age-related hypogonadism specifically |
Recommended dose (if used): 250–750 mg/day standardised to ≥40% saponins. The evidence does not support its routine use as a testosterone-boosting supplement in healthy men.
7. Stinging Nettle Root (Urtica dioica)
Mechanism:
Nettle root’s primary testosterone-related mechanism involves inhibition of sex hormone-binding globulin (SHBG). Lignans in the root — particularly 3,4-divanillyltetrahydrofuran (DVTHF) — compete with testosterone for SHBG binding sites, thereby increasing the circulating free testosterone fraction without necessarily increasing total testosterone production. Nettle root also contains beta-sitosterol, which modulates 5-alpha-reductase activity, and has been shown to inhibit aromatase activity in in-vitro assays.
Clinical evidence:
In-vitro studies by Hryb et al. (1995) demonstrated that nettle root lignans significantly displaced testosterone from SHBG with high binding affinity — robust mechanistic evidence for the free testosterone liberation hypothesis. Human in-vivo evidence is more limited: a combined formulation study of nettle root and saw palmetto in men with benign prostatic hyperplasia (BPH) showed improvement in testosterone ratios and urinary symptoms, though isolating nettle root’s independent contribution is difficult. Nettle root is more extensively studied in BPH and prostate health contexts than in androgen optimisation, and dedicated testosterone RCTs remain absent from the literature.
Age group assessment:
| Age Group | Efficacy Score | Likelihood of Benefit | Notes |
| 20–35 | 4/10 | Low (25–35%) | SHBG is not typically elevated in young men; mechanism less relevant |
| 36–55 | 5.5/10 | Moderate (45–55%) | SHBG rises progressively with age; mechanism becomes more clinically important |
| 56+ | 6.5/10 | Moderate–High (55–65%) | Best-fit candidate for older men with confirmed high SHBG |
Recommended dose: 300–600 mg/day of nettle root extract standardised to ≥1% sitosterols. Best used as part of a combination stack targeting free testosterone in older men.
8. Panax Ginseng (Panax ginseng)
Mechanism:
Ginsenosides — the key bioactive compounds — modulate nitric oxide synthase activity (directly relevant to erectile function and vascular health), influence hypothalamic and pituitary signalling, and exert protective antioxidant effects in gonadal tissue. In-vitro studies have demonstrated that ginsenosides Rg1 and Rb1 directly stimulate testosterone production in cultured Leydig cells. Human trials show modest effects on free testosterone alongside significant functional benefits for sexual performance and fatigue.
Clinical evidence:
A meta-analysis by Leung & Wong (2013) found that Panax ginseng significantly improved erectile dysfunction compared to placebo across multiple trials. A Korean RCT study found that 1,000 mg three times daily for 8 weeks raised free testosterone in middle-aged men. In-vitro studies are consistent in demonstrating ginsenoside-mediated stimulation of Leydig cell steroidogenesis. The evidence for meaningful serum testosterone elevation in healthy young men remains weak, but the functional improvements in energy, sexual function, and cognitive performance are among the most consistently documented in herbal medicine.
Age group assessment:
| Age Group | Efficacy Score | Likelihood of Benefit | Notes |
| 20–35 | 5.5/10 | Moderate (45–55%) | Better evidence for vitality and performance than raw testosterone elevation |
| 36–55 | 6/10 | Moderate (50–60%) | Free testosterone improvements documented; strong evidence for erectile function |
| 56+ | 6.5/10 | Moderate–High (55–65%) | Strongest evidence for erectile function, energy, and gonadal antioxidant protection in older men |
Recommended dose: 200–400 mg/day of standardised Panax ginseng extract standardised to ≥5% ginsenosides (Korean Red Ginseng equivalent: 1,000–3,000 mg/day of whole root powder).
9. Boron
Mechanism:
Boron is a dietary trace mineral that influences steroid hormone metabolism at the enzymatic level. It reduces the activity of SHBG and 17-beta-hydroxysteroid dehydrogenase, shifting the hormonal balance toward greater free testosterone and lower oestradiol. It also enhances the body’s utilisation of vitamin D and magnesium — two micronutrients with well-established roles in testosterone synthesis and androgen receptor sensitivity. Observational data associates low dietary boron intake with lower serum testosterone across multiple population cohorts.
Clinical evidence:
A clinical study by Naghii et al. (2011) found that just 10 mg/day of boron supplementation for one week in healthy male volunteers produced a 28% increase in free testosterone and a 39% reduction in oestradiol. A longer 60-day trial confirmed sustained improvements in free testosterone alongside maintained SHBG suppression. In-vivo animal studies show dose-dependent increases in serum testosterone. The rapidity of the effect — detectable within one week — makes boron mechanistically interesting as a hormone-modulating mineral rather than a classical adaptogen.
Age group assessment:
| Age Group | Efficacy Score | Likelihood of Benefit | Notes |
| 20–35 | 5/10 | Moderate (40–50%) | Most useful if diet is boron-deficient; effect on eugonadal men is modest |
| 36–55 | 6.5/10 | Moderate–High (55–65%) | Increasingly relevant as SHBG and oestrogen ratios rise with age |
| 56+ | 7/10 | High (60–70%) | Potent free testosterone effect via SHBG suppression; oestradiol reduction especially relevant |
Recommended dose: 6–10 mg/day of elemental boron as boron citrate or calcium fructoborate. Best paired with adequate vitamin D and magnesium.
10. Mucuna Pruriens (Velvet Bean)
Mechanism:
Mucuna is one of the richest known natural sources of L-DOPA, the immediate precursor to dopamine. Dopamine exerts tonic inhibitory control over prolactin secretion from the anterior pituitary. Elevated prolactin — common in stressed, sleep-deprived, or ageing men — suppresses the HPG axis and reduces testosterone. By raising dopamine tone, Mucuna disinhibits the HPG axis, allowing normalisation of LH and downstream testosterone production. Additionally, Mucuna contains compounds that appear to directly stimulate LH release independent of the dopamine pathway. It is mechanistically most relevant in men with stress-driven hyperprolactinaemia, dopaminergic decline, or subfertility.
Clinical evidence:
A clinical study by Shukla et al. (2010) in infertile men found that 5 g/day of Mucuna seed powder over 3 months increased testosterone by approximately 38%, LH by 41%, dopamine by 27%, and reduced prolactin by 32% — the most complete mechanistic hormonal profile of any herb reviewed here. In-vivo rat studies consistently show significant increases in testosterone following Mucuna extract administration. The key limitation is that human evidence is largely confined to subfertile or hyperprolactinaemic populations, limiting direct generalisability to healthy men. However, the mechanistic pathway is well-characterised and physiologically plausible across a wider population.
Age group assessment:
| Age Group | Efficacy Score | Likelihood of Benefit | Notes |
| 20–35 | 5.5/10 | Moderate (45–55%) | Most relevant in stressed, hyperprolactinaemic, or subfertile young men |
| 36–55 | 6/10 | Moderate (50–60%) | L-DOPA support benefits men with declining dopaminergic tone; relevant in chronic stress |
| 56+ | 5/10 | Moderate (40–50%) | HPG axis responsiveness to dopaminergic stimulation is attenuated in advanced age |
Recommended dose: 5 g/day of whole seed powder, or 300–500 mg/day of standardised extract standardised to ≥15% L-DOPA.
Several important patterns emerge from synthesising this body of evidence.
The first and perhaps most clinically important finding is that testosterone response to herbal supplementation is heavily population-dependent. No herb reviewed here works equally well for all men at all life stages. The clearest example is Tongkat Ali, which has produced null results in healthy eugonadal men under 35 in placebo-controlled trials, yet has demonstrated significant, reproducible testosterone increases — confirmed by a 2022 meta-analysis of nine RCTs with a pooled effect size of SMD 1.352 — in men with low-normal or subnormal testosterone, particularly those aged 36 and above. Ashwagandha follows a similar pattern: its most dramatic effects are seen in men whose testosterone is being chronically suppressed by elevated cortisol, making it most potent in stressed, sleep-deprived, or overtrained individuals regardless of age.
The second key finding is that the mechanism of action matters as much as the herb itself when matching a supplement to an individual. Men whose primary issue is high SHBG sequestering their free testosterone are better served by Tongkat Ali, boron, or stinging nettle root than by cortisol-targeting adaptogens. Men whose testosterone is suppressed by stress and high prolactin may respond better to ashwagandha and Mucuna pruriens. Older men experiencing the mitochondrial energy decline that impairs Leydig cell steroidogenesis have the strongest mechanistic case for Shilajit. Matching mechanism to biology, rather than selecting herbs based on marketing claims, is the most rational approach to natural testosterone optimisation.
The third finding concerns the quality and consistency of the evidence base. Ashwagandha and Tongkat Ali currently have the most robust clinical evidence, each supported by multiple RCTs and confirmatory meta-analyses. Fenugreek and boron have strong supporting data from well-designed individual trials. Shilajit holds promise but requires more large-scale RCT replication. Maca and Tribulus, despite their enormous commercial popularity, have the weakest evidence for actual testosterone elevation in healthy men — their benefits, where genuine, lie more in the domains of libido, sexual function, and sperm quality.
Fourth, standardisation of herbal extracts is not a secondary concern — it is central to whether these supplements work at all. The dramatic variability in commercial product quality, particularly for Tongkat Ali (where eurycomanone content can range from negligible to clinically meaningful), accounts for much of the inconsistency between consumer experience and clinical trial outcomes. Where possible, men should seek preparations that match the standardised extracts used in positive clinical trials.
Finally, it should be emphasised that no herb reviewed in this article replaces a healthy lifestyle as the foundation of hormonal health. The clinical trial literature on Tongkat Ali specifically demonstrates that its testosterone-raising effects are significantly amplified when combined with concurrent resistance and aerobic training — an interaction not observed with most pharmaceutical interventions. Sleep quality, dietary sufficiency in zinc and vitamin D, stress management, and body composition remain the most powerful natural determinants of testosterone across all age groups. These herbs are best understood as evidence-informed adjuncts to, rather than substitutes for, the lifestyle foundations that hormone health ultimately rests upon.
Men experiencing symptoms consistent with low testosterone should seek baseline blood work — including total testosterone, free testosterone, SHBG, LH, FSH, oestradiol, and prolactin — before selecting any supplement. That hormonal profile, combined with age and presenting symptoms, should guide herb selection far more reliably than any generic recommendation.
Natural testosterone optimisation is a long game. It rewards patience, consistency, and biological self-awareness far more than it rewards impulse-buying the latest bestselling supplement. The herbs are real, the evidence is growing, and for the right man in the right context, the results can be genuinely significant. The key is knowing whether you are that man — and this article has been written to help you find out.
If there is one takeaway from everything reviewed in this article, it is this: the right herb for the right man at the right life stage, backed by a standardised, clinically validated extract, can make a genuine and measurable difference to hormonal health. But that same herb, taken by the wrong person without regard for their individual biology, may do very little at all.
For men in their twenties and early thirties with healthy baseline testosterone, the honest answer is that most of these herbs will not dramatically move the needle on serum levels. What they may do — particularly ashwagandha, Tongkat Ali under conditions of stress, and Panax ginseng — is protect the testosterone you already have from being eroded by the cortisol load of modern life. That is a meaningful benefit in its own right, even if it does not show up as a dramatic percentage increase on a lab report.
For men in the 36–55 window, this is where the evidence becomes most compelling. Ashwagandha and Tongkat Ali in particular have their strongest RCT evidence base in this cohort. If you are in this age group and your testosterone is trending low-normal, combining one of these two well-evidenced herbs with consistent resistance training, adequate sleep, and dietary sufficiency in zinc and vitamin D is about as evidence-informed a natural protocol as currently exists.
Chinnappan, S. M., George, A., Pandey, P., Narke, G., & Choudhary, Y. K. (2021). Effect of Eurycoma longifolia standardised aqueous root extract — Physta® on testosterone levels and quality of life in ageing male subjects: A randomised, double-blind, placebo-controlled multicentre study. Food & Nutrition Research, 65. https://doi.org/10.29219/fnr.v65.5647
Chan, K. Q., Stewart, C., Chester, N., Hamzah, S. H., & Yusof, A. (2021). The effect of Eurycoma longifolia on the regulation of reproductive hormones in young males. Andrologia, 53(1), e14001. https://doi.org/10.1111/and.14001
George, A., & Henkel, R. (2014). Phytoandrogenic properties of Eurycoma longifolia as a natural alternative to testosterone replacement therapy. Andrologia, 46(7), 708–721. https://doi.org/10.1111/and.12214
Gonzales, G. F., Cordova, A., Vega, K., Chung, A., Villena, A., Gonez, C., & Castillo, S. (2003). Effect of Lepidium meyenii (MACA) on sexual desire and its absent relationship with serum testosterone levels in adult healthy men. Andrologia, 34(6), 367–372. https://doi.org/10.1046/j.1439-0272.2002.00519.x
Hamzah, S., & Yusof, A. (2003). The ergogenic effects of Eurycoma longifolia Jack: A pilot study. British Journal of Sports Medicine, 37, 464–470. https://doi.org/10.1136/bjsm.37.5.464
Henkel, R. R., Wang, R., Bassett, S. H., Chen, T., Liu, N., Zhu, Y., & Tambi, M. I. (2014). Tongkat Ali as a potential herbal supplement for physically active male and female seniors — a pilot study. Phytotherapy Research, 28(4), 544–550. https://doi.org/10.1002/ptr.5017
Hryb, D. J., Khan, M. S., Romas, N. A., & Rosner, W. (1995). The effect of extracts of the roots of the stinging nettle (Urtica dioica) on the interaction of SHBG with its receptor on human prostatic membranes. Planta Medica, 61(1), 31–32. https://doi.org/10.1055/s-2006-957993
Ismail, S. B., Wan Mohammad, W. M. Z., George, A., Nik Hussain, N. H., Musthapa Kamal, Z. M., & Liske, E. (2012). Randomized clinical trial on the use of PHYSTA freeze-dried water extract of Eurycoma longifolia for the improvement of quality of life and sexual well-being in men. Evidence-Based Complementary and Alternative Medicine, 2012, 429268. https://doi.org/10.1155/2012/429268
Leisegang, K., Finelli, R., Sikka, S. C., & Panner Selvam, M. K. (2022). Eurycoma longifolia (Jack) improves serum total testosterone in men: A systematic review and meta-analysis of clinical trials. Medicina, 58(8), 1047. https://doi.org/10.3390/medicina58081047
Leung, K. W., & Wong, A. S. T. (2013). Ginseng and male reproductive function. Spermatogenesis, 3(3), e26391. https://doi.org/10.4161/spmg.26391
Lopresti, A. L., Drummond, P. D., & Smith, S. J. (2019). A randomized, double-blind, placebo-controlled, crossover study examining the hormonal and vitality effects of ashwagandha (Withania somnifera) in aging, overweight males. American Journal of Men’s Health, 13(2), 1557988319835985. https://doi.org/10.1177/1557988319835985
Maheshwari, A., Verma, N., Swaroop, A., Bagchi, M., Preuss, H. G., Tiwari, K., & Bagchi, D. (2017). Efficacy of Furosap, a novel Trigonella foenum-graecum seed extract, in enhancing testosterone level and improving sperm profile in male volunteers. Archives of Medical Science, 13(2), 396–402. https://doi.org/10.5114/aoms.2017.65828
Naghii, M. R., Mofid, M., Asgari, A. R., Hedayati, M., & Daneshpour, M. S. (2011). Comparative effects of daily and weekly boron supplementation on plasma steroid hormones and proinflammatory cytokines. Journal of Trace Elements in Medicine and Biology, 25(1), 54–58. https://doi.org/10.1016/j.jtemb.2010.10.001
Pandit, S., Biswas, S., Jana, U., De, R. K., Mukhopadhyay, S. C., & Biswas, T. K. (2016). Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers. Andrologia, 48(5), 570–575. https://doi.org/10.1111/and.12482
Qureshi, A., Naughton, D. P., & Petroczi, A. (2014). A systematic review on the herbal extract Tribulus terrestris and the roots of its putative aphrodisiac and performance enhancing effect. Journal of Dietary Supplements, 11(1), 64–79. https://doi.org/10.3109/19390211.2014.887602
Roaiah, M. F., El Khayat, Y. I., Gamal El Din, S. F., & Abd El Salam, M. A. (2016). Pilot study on the effect of botanical medicine (Tribulus terrestris) on serum testosterone level and erectile function in aging males with partial androgen deficiency. Journal of Sex and Marital Therapy, 42(4), 297–301. https://doi.org/10.1080/0092623X.2015.1033579
Shin, B. C., Lee, M. S., Yang, E. J., Lim, H. S., & Ernst, E. (2010). Maca (L. meyenii) for improving sexual function: A systematic review. BMC Complementary and Alternative Medicine, 10, 44. https://doi.org/10.1186/1472-6882-10-44
Shukla, K. K., Mahdi, A. A., Ahmad, M. K., Shankhwar, S. N., Rajender, S., & Jaiswar, S. P. (2009). Mucuna pruriens improves male fertility by its action on the hypothalamus-pituitary-gonadal axis. Fertility and Sterility, 92(6), 1934–1940. https://doi.org/10.1016/j.fertnstert.2008.09.045
Steels, E., Rao, A., & Vitetta, L. (2011). Physiological aspects of male libido enhanced by standardized Trigonella foenum-graecum extract and mineral formulation. Phytotherapy Research, 25(9), 1294–1300. https://doi.org/10.1002/ptr.3360
Talbott, S. M., Talbott, J. A., George, A., & Pugh, M. (2013). Effect of Tongkat Ali on stress hormones and psychological mood state in moderately stressed subjects. Journal of the International Society of Sports Nutrition, 10, 28. https://doi.org/10.1186/1550-2783-10-28
Tambi, M. I., & Imran, M. K. (2010). Eurycoma longifolia Jack in managing idiopathic male infertility. Asian Journal of Andrology, 12(3), 376–380. https://doi.org/10.1038/aja.2010.7
Tambi, M. I., Imran, M. K., & Henkel, R. R. (2012). Standardised water-soluble extract of Eurycoma longifolia, Tongkat Ali, as testosterone booster for managing men with late-onset hypogonadism. Andrologia, 44(Suppl. 1), 226–230. https://doi.org/10.1111/j.1439-0272.2011.01168.x
Wankhede, S., Langade, D., Joshi, K., Sinha, S. R., & Bhattacharyya, S. (2015). Examining the effect of Withania somnifera supplementation on muscle strength and recovery: A randomized controlled trial. Journal of the International Society of Sports Nutrition, 12, 43. https://doi.org/10.1186/s12970-015-0104-9
Yap Soo Ват, A., Leitão, L., Campos, P., Teixeira, A. M., & Conceição, M. S. (2021). A 6-month, double-blind, placebo-controlled, randomized trial to evaluate the effect of Eurycoma longifolia (Tongkat Ali) and concurrent training on erectile function and testosterone levels in androgen deficiency of aging males (ADAM). Maturitas, 145, 55–62. https://doi.org/10.1016/j.maturitas.2020.12.004
Alex Kua leads AKARALI’s Global Partnership Community to help athletes, sports communities, and thousand of others optimize their well-being through evidence-based research that enables them to make better informed decisions. His legal and business consulting background underpins the rigorous data-driven approach in his writing – from hours of interviews, real-world performance data, and firsthand experiences of real people – offering actionable insights that connects clinical research, emerging health trends, and real-world applications. He is also an experienced researcher in herbal nutrition, with years of deep technical knowledge on Tongkat Ali (Eurycoma longifolia), including quality standards, industry benchmarks, lab tests, clinical trials, and the use of natural herbs by collaborating with top scientists, herbal experts, and nutritionists. As part of the core team behind AKARALI’s knowledge portal, he empowers people worldwide to access the benefits of high-quality herbal nutrition in a way that is effective, sustainable, and safe. He is also an avid runner, with regular participation in local sports communities and running events.
Our articles are third party reviewed by our panel of experts and medical advisors to ensure the facts are accurate and credible. These are validated against multiple source references which include but not limited to research studies, peer-reviewed journals, pre-clinical studies, clinical tests and other credible publications.
Our panel of medical advisors and experts are highly experienced in their individual fields. However, they do not provide any medical advice or recommendations arising from content published in this article.
Disclaimer:
The content published on this website is for educational purposes and should not be viewed, read, or seen as a prescription or constitute any form of medical advice. We recommend you consult your nearest GP or doctors before consuming Tongkat Ali or any products which contain Tongkat Ali. For further information, kindly refer to our Frequently Asked Questions (FAQ) for more information.
